AnaptysBio
ANAB
45.65
-2.24
-4.68%
AnaptysBio
US · ANAB
#3010 by market cap
Listed 2017
45.65
-2.24
-4.68%
Live - 5344 symbols - heartbeat 313s ago
· 2026-10-08 08:13
Pre-market
45.63
-0.04%
After-hours
45.65
0.00%
- Market cap
- 1.36B
- P/E (TTM)i
- 8.15
- P/Bi
- 128.95
- EPSi
- 5.60
- Div yieldi
- 0.00%
- 52W posi
- 49%
Reader sentiment
Are you bullish or bearish on ANAB?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 0.96, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -77.39% YoY
Margins
Key ratios & quality
- Altman Z-Scorei
- 0.96
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 8.00M | 75.00M | 63.18M | 10.29M | 17.16M | 91.28M | 234.60M | 53.04M |
| Gross profit | -- | -- | -- | -- | -- | -- | -- | -- |
| Selling & admin expenses | 16.09M | 18.85M | 21.49M | 36.64M | 41.95M | 13.63M | 11.35M | 23.39M |
| Research & development | 99.34M | 80.03M | 98.50M | 88.80M | 132.28M | 11.50M | -3.64M | -2.67M |
| Operating profit | -107.43M | -23.88M | -56.81M | -115.15M | -157.07M | 66.15M | 226.90M | 32.32M |
| Pretax profit | -97.49M | -19.93M | -57.80M | -128.70M | -163.62M | 31.14M | 162.28M | -5.09M |
| Tax | -152.00K | 0 | 0 | 24.00K | -4.00K | 158.00K | 772.00K | -181.45M |
| Net profit | -97.34M | -19.93M | -57.80M | -128.72M | -163.62M | -145.23M | -13.23M | 131.00M |
| Basic EPS | -4 | -1 | -2 | -5 | -6 | -5 | 0 | 5 |
| Diluted EPS | -3.60 | -0.73 | -2.11 | -4.57 | -6.08 | -5.12 | -0.46 | 3.50 |
| Line item | 2024-12 | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 |
|---|---|---|---|---|---|---|
| Revenue | 43.11M | 27.77M | 22.26M | 76.32M | 108.25M | 25.56M |
| Gross profit | -- | -- | -- | -- | -- | -- |
| Selling & admin expenses | -18.56M | 14.13M | 10.61M | 10.21M | -23.60M | 26.20M |
| Research & development | -109.76M | 41.18M | 37.82M | 31.41M | -114.06M | 33.99M |
| Operating profit | 171.43M | -27.54M | -26.17M | 34.70M | 245.91M | -34.64M |
| Pretax profit | 154.58M | -39.29M | -38.59M | 15.11M | 225.04M | -52.84M |
| Tax | 149.00K | 44.00K | 39.00K | 0 | 689.00K | 40.00K |
| Net profit | -21.78M | -39.33M | -38.63M | 15.11M | 49.61M | -52.88M |
| Basic EPS | -1 | -1 | -1 | 1 | 2 | -2 |
| Diluted EPS | -0.72 | -1.28 | -1.34 | 0.52 | 1.58 | -1.84 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 377.73M | 396.56M | 553.88M | 447.21M | 406.84M | 431.88M | 350.25M | 198.43M |
| Cash & ST investments | 374.23M | 393.65M | 548.10M | 441.24M | 390.90M | 285.37M | 211.64M | 164.14M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 435.20M | 416.55M | 643.07M | 610.38M | 452.39M | 483.83M | 364.40M | 316.98M |
| Total current liabilities | 29.54M | 19.82M | 16.10M | 26.05M | 37.44M | 45.43M | 38.63M | 35.35M |
| Short-term debt | 2.25M | 342.00K | 1.51M | 1.64M | 1.78M | 1.93M | 2.08M | 2.16M |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 30,189,000.00 | 19,821,000.00 | 286,642,000.00 | 348,280,000.00 | 364,286,000.00 | 412,966,000.00 | 327,185,000.00 | 306,399,000.00 |
| Total equity | 405.01M | 396.73M | 356.43M | 262.10M | 88.10M | 70.87M | 37.21M | 10.59M |
| Retained earnings | -244.03M | -263.96M | -321.75M | -450.48M | -614.10M | -759.33M | -772.56M | -641.56M |
| Line item | 2024-12 | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 |
|---|---|---|---|---|---|---|
| Total current assets | 431.88M | 363.11M | 291.91M | 330.65M | 350.25M | 316.11M |
| Cash & ST investments | 285.37M | 339.94M | 265.71M | 248.96M | 211.64M | 286.46M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 483.83M | 422.05M | 335.25M | 353.10M | 364.40M | 329.68M |
| Total current liabilities | 45.43M | 44.04M | 35.53M | 38.10M | 38.63M | 41.70M |
| Short-term debt | 1.93M | 1.96M | 2.00M | 2.04M | 2.08M | 2.12M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 412,966,000.00 | 388,032,000.00 | 379,983,000.00 | 382,514,000.00 | 327,185,000.00 | 316,937,000.00 |
| Total equity | 70.87M | 34.02M | -44.73M | -29.42M | 37.21M | 12.75M |
| Retained earnings | -759.33M | -798.66M | -837.29M | -822.17M | -772.56M | -825.44M |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -69.52M | -14.16M | -45.92M | -73.59M | -120.80M | -135.34M | 19.70M | -52.56M |
| Depreciation & amortization | 1.41M | 1.62M | 2.09M | 2.34M | 2.38M | 1.81M | 1.88M | 968.00K |
| Free cash flow | -70.32M | -14.73M | -47.29M | -73.95M | -121.61M | -135.34M | 19.70M | -52.56M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 3.01M | 496.00K | 2.55M | 11.83M | -47.53M | 100.39M | -54.37M | 25.37M |
| Ending cash balance | 171.08M | 250.52M | 495.73M | 71.31M | 35.97M | 23.08M | 138.20M | 133.83M |
| Line item | 2024-12 | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 |
|---|---|---|---|---|---|---|
| Operating cash flow | -66.67M | -10.70M | -40.24M | -27.36M | 98.00M | -25.92M |
| Depreciation & amortization | 15.00K | 606.00K | 601.00K | 610.00K | 67.00K | 610.00K |
| Free cash flow | -66.58M | -10.74M | -40.28M | -27.37M | 98.08M | -25.94M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 99.00K | -4.13M | -49.68M | -9.38M | 8.83M | 14.02M |
| Ending cash balance | 23.08M | 98.64M | 44.30M | 109.83M | 138.20M | 248.47M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -21.84 | -4.97 | -15.35 | -41.62 | -93.44 | -182.71 | -24.49 | -- |
| ROA %i | -20.62 | -4.68 | -10.91 | -20.54 | -30.79 | -31.02 | -3.12 | -- |
| ROIC %i | -23.80 | -5.94 | -14.30 | -36.02 | -84.86 | -127.27 | 52.36 | -- |
| 5-year avg ROE %i | -- | -- | -16.00 | -19.86 | -35.44 | -67.62 | -71.52 | -- |
| EBIT margin %i | -1,205.59 | -26.57 | -89.19 | -1,045.90 | -848.28 | -104.23 | 28.48 | -- |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | 8.36 | -- |
| Current ratioi | 12.79 | 20.01 | 34.40 | 17.16 | 10.87 | 9.51 | 9.07 | -- |
| Quick ratioi | 12.67 | 19.86 | 34.10 | 16.99 | 10.62 | 7.18 | 6.36 | -- |
| Debt / assetsi | 0.67 | 0.08 | 3.26 | 3.19 | 3.94 | 3.31 | 3.87 | -- |
| LT debt / equityi | 0.16 | -- | 5.46 | 6.80 | 18.20 | 19.91 | 32.34 | -- |
| Interest coveragei | -92.65 | -- | -38.86 | -5.10 | -8.05 | -1.90 | 0.84 | -- |
| Revenue CAGR (3Y) %i | -21.73 | 95.74 | 132.91 | 8.74 | -38.84 | 13.05 | 183.58 | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2024-12 | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 |
|---|---|---|---|---|---|---|
| ROE %i | -182.71 | -343.83 | -- | -308.02 | -24.49 | -114.55 |
| ROA %i | -31.02 | -33.97 | -34.77 | -19.99 | -3.12 | -7.13 |
| ROIC %i | -127.27 | -190.32 | -- | -90.60 | 52.36 | 41.56 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -104.23 | -70.39 | -50.37 | -4.11 | 28.48 | 24.13 |
| FCF / sales %i | -- | -- | -- | -- | 8.36 | 1.90 |
| Current ratioi | 9.51 | 8.25 | 8.22 | 8.68 | 9.07 | 7.58 |
| Quick ratioi | 7.18 | 8.13 | 8.08 | 8.52 | 6.36 | 7.49 |
| Debt / assetsi | 3.31 | 3.69 | 4.50 | 4.14 | 3.87 | 4.13 |
| LT debt / equityi | 19.91 | 40.01 | -- | -- | 32.34 | 90.16 |
| Interest coveragei | -1.90 | -1.27 | -0.88 | -0.09 | 0.84 | 0.68 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Royalty Management100.00%
Region
United States100.00%
Quote time 2026-10-08 08:13:02 · For reference only, not investment advice and not tailored to your situation.